HCXY Market Analysis
News & Sentiment
44 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- 5.0%
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Hercules Capital, Inc.
Company profileHercules Capital, Inc. (HCXY) is a leading publicly traded business development company that focuses on providing tailored financing solutions primarily to the life sciences and technology sectors. With a commitment to capital preservation and achieving risk-adjusted returns, Hercules leverages its deep industry knowledge and strategic alliances to offer both debt and equity investments that support innovation and growth. By strategically identifying high-potential firms in competitive markets, Hercules positions itself as an appealing financial partner for institutional investors aiming for…
Classification
- Sector
- Financials
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NONE
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer